eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/1999
vol. 3
 
Share:
Share:
abstract:

Biological and clinical impact of IL-6 production by ovarian carcinoma cells

Andrzej Lange
,
Ilona Kryczek
,
Marian Gryboś

Współcz Onkol (1999) 3 (5), 195-198
Online publish date: 2003/08/06
View full text Get citation
 
In this review article some information is presented regarding of the biological impact of interleukin 6 (IL-6) production by ovarian carcinoma. This is illustrated by elevation of C-reactive protein (CRP) in sera of ovarian carcinoma patients and a fair degree correlation between ascites IL-6 levels and platelet count. IL-6 is physiologically produced by ovarian granulosa cells and this production is regulated by gonadotropin activity. In ovarian carcinoma patients IL-6 production is highly elevated and automonous. This is suggested by higher level of IL-6 generation in carcinomatous than in benign cysts. Ovarian cancer IL-6 generation is associated with tumour morphology; papillare cancers and mucous/serous tumours are good producers of IL-6. Ability of ovarian carcinoma cells to produce IL-6 likely reflects the level of differentiation of ovarian cell which is transformed to carcinoma cell. IL-6 and its reading protein CRP maybe regarded as markers of ovarian tumours with the potential to modulate local immunity.
keywords:

ovarian carcinoma, IL-6, peritoneal fluid, CRP, memory cells, CD45RO

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.